HSP<>Hospira ups guidance after Q2 results Hospira (NYSE:HSP) Q2 results: Net Sales: $1,135.8M (+10.7%); Operating Expenses: $1,036.3M (+6.4%); Operating Income: $99.5M (+90.6%); Net Income: $70.9M (+115.5%); EPS: $0.42 (+110.0%); CF Ops (6 mo.): $175.5M (+246.8%). 2014 Guidance: Net sales growth: 6 - 9%; non-GAAP EPS: $2.30 - 2.50 from $2.00 - 2.25; GAAP EPS: $1.09 - 1.29; CF Ops: $275M - 375M; CAPEX: $375M - 425M (unch).